Bacterial carbonic anhydrases: underexploited antibacterial therapeutic targets-Reference-Cited by-同舟云学术

Bacterial carbonic anhydrases: underexploited antibacterial therapeutic targets

Published:2021-10 Issue:19 Volume:13 Page:1619-1622
ISSN:1756-8919
Container-title:Future Medicinal Chemistry
language:en
Short-container-title:Future Medicinal Chemistry

Author:

P Flaherty Daniel¹^ORCID,N Seleem Mohamed²^ORCID,T Supuran Claudiu³^ORCID

Affiliation:

1. Department of Medicinal Chemistry & Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN 47907, USA

2. Department of Biomedical Sciences & Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute & State University, Blacksburg, VA 24061, USA

3. Department of NEUROFARBA, Section of Pharmaceutical & Nutraceutical Sciences, University of Florence, Polo Scientifico, Firenze, 50122, Italy

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Future Science Ltd

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.future-science.com/doi/pdf/10.4155/fmc-2021-0207

Reference20 articles.

1. Structure and function of carbonic anhydrases

2. Clapp JW, Roblin JRO. US2554816A (1951).

3. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators

4. Emerging role of carbonic anhydrase inhibitors

5. Bacterial, fungal and protozoan carbonic anhydrases as drug targets

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibacterial carbonic anhydrase inhibitors targeting Vibrio cholerae enzymes;Expert Opinion on Therapeutic Targets;2024-07-02

2. Fighting antibacterial drug resistance;Expert Opinion on Therapeutic Patents;2024-06-02

3. Management of Neisseria gonorrhoeae infection: from drug resistance to drug repurposing;Expert Opinion on Therapeutic Patents;2024-06-02

4. Biomedical applications of prokaryotic carbonic anhydrases: an update;Expert Opinion on Therapeutic Patents;2024-05-03

5. Novel carbonic anhydrase inhibitors for the treatment of Helicobacter pylori infection;Expert Opinion on Investigational Drugs;2024-03-27